LIFECORE BIOMEDICAL, INC. \DE\

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $9.9m $5.4m $2.9m $1.1m $360k $1.3m $1.6m $3.0m $8.5m $17.5m
Prepaid Expense and Other Assets, Current $4.6m $3.5m $8.0m $8.3m $14.2m $7.3m $7.1m $1.5m $1.4m $1.9m
Inventory, Net $25.5m $25.3m $31.8m $54.1m $66.3m $69.7m $66.8m $42.0m $40.0m $29.1m
Assets, Current $86.5m $81.3m $97.1m $133.0m $157.1m $148.3m $123.7m $83.1m $81.0m $82.3m
Property, Plant and Equipment, Net $120.9m $133.2m $159.6m $200.0m $192.3m $179.6m $118.5m $126.3m $148.6m $127.3m
Goodwill $49.6m $54.8m $54.5m $76.7m $69.4m $69.4m $13.9m $13.9m $13.9m $13.9m
Intangible Assets, Net (Excluding Goodwill) $4.2m
Operating Lease, Right-of-Use Asset $25.3m $20.8m $8.6m $5.1m $2.4m
Other Assets, Noncurrent $2.4m $2.9m $5.2m $2.9m $2.2m $3.6m $3.0m $2.7m $3.8m $8.7m
Additional Financial Items
Accounts Receivable, after Allowance for Credit Loss, Current $46.4m $47.1m $53.9m $69.6m $76.2m $70.0m $48.2m $31.0m $31.2m $28.7m
Accrued Liabilities, Current $22.5m $17.7m
Assets $343.5m $358.6m $404.7m $519.1m $541.3m $502.9m $277.8m $236.7m $254.0m $232.2m
LIABILITIES AND EQUITY
Current liabilities:
Operating Lease, Liability, Current $4.3m $3.8m $1.7m $4.0m $372k
Accounts Payable, Current $30.9m $25.9m $34.7m $54.0m $51.6m $47.6m $15.8m $14.7m $16.3m $5.8m
Operating Lease, Liability, Noncurrent $22.9m $20.3m $10.0m $1.7m $1.1m
Deferred Revenue, Current $832k $310k $2.6m
Long-term Debt, Current Maturities $8.0m $4.9m $4.9m $9.8m $11.6m $0 $98.2m $773k $954k
Long-term Debt, Excluding Current Maturities $46.6m $42.3m $37.4m $87.2m $101.4m $164.9m $0 $98.9m $100.8m
Liabilities, Current $56.5m $51.5m $88.4m $137.1m $164.4m $101.9m $176.8m $37.4m $38.9m $23.6m
Deferred Income Tax Liabilities, Net $13.6m $6.1m $126k $80k $543k
Other Liabilities, Noncurrent $4.6m $3.6m $190k $203k $5.1m $6.7m
Deferred Tax Liabilities, Net $28.9m $33.0m $23.2m $19.4m $13.6m $6.1m $126k $543k $578k
Liabilities $131.1m $130.5m $152.1m $248.9m $310.3m $300.1m $187.1m $163.1m $200.1m $198.1m
Stockholders’ equity:
Common Stock, Value, Issued $27k $27k $28k $29k $29k $29k $30k $30k $30k $37k
Additional Paid in Capital $137.2m $141.7m $142.1m $160.3m $162.6m $165.5m $167.4m $174.2m $177.8m $209.0m
Retained Earnings (Accumulated Deficit) $73.5m $84.5m $109.3m $109.7m $71.2m $38.6m ($76.1m) ($139.3m) ($166.5m) ($223.2m)
Accumulated Other Comprehensive Income (Loss), Net of Tax $432k $1.1m $64k ($2.8m) ($1.4m) ($586k)
Stockholders' Equity Attributable to Parent $210.7m $226.6m $252.6m $270.1m $231.0m $202.8m $90.7m $35.0m $11.3m ($14.2m)
Stockholders' Equity Attributable to Noncontrolling Interest $1.6m $1.5m
Liabilities and Equity $343.5m $358.6m $404.7m $519.1m $541.3m $502.9m $277.8m $236.7m $254.0m $232.2m